These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 26899631)

  • 1. Development of a decision aid for the treatment of benign prostatic hyperplasia: A four stage method using a Delphi consensus study.
    Lamers RED; Cuypers M; Garvelink MM; de Vries M; Bosch JLHR; Kil PJM
    Patient Educ Couns; 2016 Jul; 99(7):1249-1256. PubMed ID: 26899631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of a web-based treatment decision aid for men with lower urinary tract symptoms due to benign prostatic hyperplasia.
    van der Wijden FC; de Angst IB; Lamers RED; Cuypers M; de Vries M; van Melick HHE; de Beij JS; Oerlemans DJAJ; van de Beek K; Kil PJM
    BJU Int; 2019 Jul; 124(1):124-133. PubMed ID: 30589205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment Preferences of Patients With Benign Prostatic Hyperplasia Before and After Using a Web-based Decision Aid.
    Lamers RED; van der Wijden FC; de Angst IB; de Vries M; Cuypers M; van Melick HHE; de Beij JS; Oerlemans DJAJ; van de Beek K; Bosch RJLHR; Kil PJM
    Urology; 2020 Mar; 137():138-145. PubMed ID: 31899227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Guide dedicated to general practitioner for the management of lower urinary tract symptoms related to benign prostatic hyperplasia].
    Descazeaud A; Barry Delongchamps N; Cornu JN; Azzouzi AR; Buchon D; Benchikh A; Coloby P; Dumonceau O; Fourmarier M; Haillot O; Lebdai S; Mathieu R; Misrai V; Saussine C; de La Taille A; Robert G;
    Prog Urol; 2015 Jun; 25(7):404-12. PubMed ID: 25841758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Initial assessment, follow-up and treatment of lower urinary tract symptoms related to benign prostatic hyperplasia: guidelines of the LUTS committee of the French Urological Association].
    Descazeaud A; Robert G; Delongchamps NB; Cornu JN; Saussine C; Haillot O; Devonec M; Fourmarier M; Ballereau C; Lukacs B; Dumonceau O; Azzouzi AR; Faix A; Desgrandchamps F; de la Taille A;
    Prog Urol; 2012 Dec; 22(16):977-88. PubMed ID: 23178093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benign prostatic hyperplasia and urinary symptoms: Evaluation and treatment.
    Mobley D; Feibus A; Baum N
    Postgrad Med; 2015 Apr; 127(3):301-7. PubMed ID: 25823641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of medical therapy or surgery on prostatic and bladder resistive indices in patients with benign prostatic hyperplasia.
    Bulut S; Ozden C; Aktas BK; Deren T; Tagci S; Gokkaya CS; Baykam MM; Memis A
    Urol Int; 2015; 94(2):181-6. PubMed ID: 25139617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Burden of male lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH) - focus on the UK.
    Speakman M; Kirby R; Doyle S; Ioannou C
    BJU Int; 2015 Apr; 115(4):508-19. PubMed ID: 24656222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survey on benign prostatic hyperplasia distribution and treatment patterns for men with lower urinary tract symptoms visiting urologists at general hospitals in Korea: a prospective, noncontrolled, observational cohort study.
    Lee SH; Chung BH; Kim CS; Lee HM; Kim CI; Yoo TK; Lee KS; Park KS; Byun SS; Yoon BI; Kim SW; Lee JY
    Urology; 2012 Jun; 79(6):1379-84. PubMed ID: 22503769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Delphi consensus study among patients and clinicians in the Netherlands on the procedure of informing young breast cancer patients about Fertility Preservation.
    Garvelink MM; Ter Kuile MM; Louwé LA; Hilders CG; Stiggelbout AM
    Acta Oncol; 2012 Nov; 51(8):1062-9. PubMed ID: 23050612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Consensus on the clinical impact of the new scientific evidence available on benign prostatic hyperplasia].
    Cózar-Olmo JM; Hernández-Fenández C; Miñana-López B; Amón-Sesmero JH; Montlleó-González M; Rodríguez-Antolín A; Caballero-Martínez F
    Actas Urol Esp; 2012 May; 36(5):265-75. PubMed ID: 22475690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient-reported outcomes in men with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) treated with intraprostatic OnabotulinumtoxinA: 3-month results of a prospective single-armed cohort study.
    Sacco E; Bientinesi R; Marangi F; Totaro A; D'Addessi A; Racioppi M; Pinto F; Vittori M; Bassi P
    BJU Int; 2012 Dec; 110(11 Pt C):E837-44. PubMed ID: 22712582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benign prostatic hyperplasia evaluation and management by urologists and primary care physicians: practice patterns from the observational BPH registry.
    Wei JT; Miner MM; Steers WD; Rosen RC; Seftel AD; Pasta DJ; Carman WJ; Roehrborn CG;
    J Urol; 2011 Sep; 186(3):971-6. PubMed ID: 21791352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality of life and clinical symptom improvement support prostatic artery embolization for patients with acute urinary retention caused by benign prostatic hyperplasia.
    Carnevale FC; da Motta-Leal-Filho JM; Antunes AA; Baroni RH; Marcelino AS; Cerri LM; Yoshinaga EM; Cerri GG; Srougi M
    J Vasc Interv Radiol; 2013 Apr; 24(4):535-42. PubMed ID: 23434084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostatic Arterial Embolization with Small Sized Particles for the Treatment of Lower Urinary Tract Symptoms Due to Large Benign Prostatic Hyperplasia: Preliminary Results.
    Li Q; Duan F; Wang MQ; Zhang GD; Yuan K
    Chin Med J (Engl); 2015 Aug; 128(15):2072-7. PubMed ID: 26228221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Convective Water Vapor Energy for Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia.
    DeLay KJ; McVary KT
    Urol Clin North Am; 2016 Aug; 43(3):371-5. PubMed ID: 27476129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Consensus document on the management and follow-up of the male with lower urinary tract symptoms secondary to benign prostate hyperplasia].
    Brenes Bermúdez FJ; Brotons Muntó F; Castiñeiras Fernández J; Cozar Olmo JM; Fernández-Pro Ledesma A; Martín Jiménez JA; Martínez-Berganza Asensio ML; Miñana López B; Molero García JM
    Semergen; 2016; 42(8):547-556. PubMed ID: 28314432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Men's theories about benign prostatic hyperplasia and prostate cancer following a benign prostatic hyperplasia decision aid.
    Holmes-Rovner M; Price C; Rovner DR; Kelly-Blake K; Lillie J; Wills C; Bonham VL
    J Gen Intern Med; 2006 Jan; 21(1):56-60. PubMed ID: 16423124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of the impact of CTMH guidelines on the management of benign prostatic hyperplasia].
    Lebdai S; Rahmène Azzouzi A; Delongchamps NB; Benchikh A; Campeggi A; Cornu JN; Dumonceau O; Faix A; Fourmarier M; Haillot O; Lukacs B; Mathieu R; Misrai V; Robert G; de La Taille A; Descazeaud A
    Prog Urol; 2015 Jan; 25(1):47-53. PubMed ID: 25453357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a North American coordinated registry network for surgical treatment of benign prostatic hyperplasia.
    Martinez Diaz S; Bhojani N; Elterman D; Zorn K; Kaplan SA; Kohler TS; Lerner LB; McVary KT; Rutman MP; Welliver C; Te AE; Sedrakyan A; Chughtai B
    World J Urol; 2022 Dec; 40(12):2991-2999. PubMed ID: 36219230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.